Virtual screening of low molecular weight mushrooms compounds as potential Mdm2 inhibitors
暂无分享,去创建一个
[1] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[2] M. Noble,et al. Understanding Small‐Molecule Binding to MDM2: Insights into Structural Effects of Isoindolinone Inhibitors from NMR Spectroscopy , 2011, Chemical biology & drug design.
[3] A. Herráez,et al. Cytotoxic action of Ganoderma lucidum on interleukin‐3 dependent lymphoma DA‐1 cells: involvement of apoptosis proteins , 2011, Phytotherapy research : PTR.
[4] J. Ungwitayatorn,et al. Molecular docking study on anticancer activity of plant-derived natural products , 2010, Medicinal Chemistry Research.
[5] Rui M. V. Abreu,et al. MOLA: a bootable, self-configuring system for virtual screening using AutoDock4/Vina on computer clusters , 2010, J. Cheminformatics.
[6] M. Vasconcelos,et al. Wild mushrooms Clitocybe alexandri and Lepista inversa: in vitro antioxidant activity and growth inhibition of human tumour cell lines. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[7] M. Vasconcelos,et al. Compounds from wild mushrooms with antitumor potential. , 2010, Anti-cancer agents in medicinal chemistry.
[8] Wei Wang,et al. Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery , 2010, Cell cycle.
[9] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[10] Xin Huang,et al. Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction. , 2009, Journal of medicinal chemistry.
[11] Brian C Grieb,et al. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. , 2008, International journal of molecular medicine.
[12] Paul Brazhnik,et al. HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery). , 2007, Mathematical biosciences.
[13] G. Hedjaroude,et al. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). , 2007, International immunopharmacology.
[14] R. Paterson,et al. Ganoderma - a therapeutic fungal biofactory. , 2006, Phytochemistry.
[15] Avram Hershko,et al. The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture). , 2005, Angewandte Chemie.
[16] U. Lindequist,et al. The Pharmacological Potential of Mushrooms , 2005, Evidence-based complementary and alternative medicine : eCAM.
[17] L. Kan,et al. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. , 2005, Life sciences.
[18] Michel F Sanner,et al. A component-based software environment for visualizing large macromolecular assemblies. , 2005, Structure.
[19] S. Wasser,et al. Medicinal mushroom modulators of molecular targets as cancer therapeutics , 2005, Applied Microbiology and Biotechnology.
[20] Maxwell D Cummings,et al. Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. , 2005, Journal of medicinal chemistry.
[21] M. Gershwin,et al. Mushrooms, Tumors, and Immunity: An Update , 2004, Experimental biology and medicine.
[22] Alessandro Pedretti,et al. VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming , 2004, J. Comput. Aided Mol. Des..
[23] Guillermina Lozano,et al. MDM2, an introduction. , 2003, Molecular cancer research : MCR.
[24] Wei Gu,et al. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. , 2003, Current opinion in cell biology.
[25] P. Chène. Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.
[26] M. Oren,et al. The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.
[27] J. Bok,et al. Antitumor sterols from the mycelia of Cordyceps sinensis. , 1999, Phytochemistry.
[28] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..
[29] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[30] S. Rapior,et al. Biological and pharmacological activity of higher fungi: 20-year retrospective analysis , 2006 .
[31] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[32] M. Hochstrasser. Ubiquitin-dependent protein degradation. , 1996, Annual review of genetics.